PCE COVID-19 Resource Center
PCE is committed to providing NPs and PAs with information, guidelines, and resources to help keep up with the rapidly evolving changes in healthcare delivery during the COVID-19 pandemic.
PCE thanks you for your commitment to healthcare and to your patients during these difficult times.
Clinical Guidelines: National & Global
Clinical Guidelines by Specialty
- American Academy of Allergy, Asthma, & Immunology
- American College of Allergy, Asthma, & Immunology
- American College of Cardiology
- American Heart Association
- Heart Failure Society of America
- American Academy of Dermatology Association
- American Diabetes Association
- American Association of Clinical Endocrinologists
- American College of Gastroenterology
- American Gastroenterological Association
- American Society of Nephrology
- American Academy of Neurology
- American College of Obstetricians and Gynecologists
- American Academy of Ophthalmology
- American Academy of Pain Medicine
- American Psychiatric Association
- American College of Chest Physicians
- American Thoracic Society
- American College of Rheumatology
- American Academy of Sleep Medicine
- American Urological Association
COVID-19: Updates From the Experts
- From IAS COVID-19 Prevention: Significant Advances in a Global Vaccination Program
- Update on Investigational Antiviral Therapies for COVID-19
- Monoclonal Antibodies Are Expanding SARS-CoV-2 Prevention and Treatment Strategies
- The IAS COVID-19 Conference: Prevention—Rapid Recap (Webcast)
- Update on Anticoagulation in Patients With COVID-19
- Diagnosis: SARS-CoV2 Antigen Testing
- Treatment Update in Covid-19
- Questions on COVID-19 Vaccines and Immunity
- COVID-19 Vaccine Updates
- COVID-19 Vaccine Hesitancy
- Updates on BTKi Therapy for COVID-19 and Considerations for Patients With CLL
- Expert Answers to Frequently Asked Questions About Chronic Lymphocytic Leukemia and COVID-19
- HIV Care During COVID-19 in México: Challenges and Solutions
- HIV and COVID-19: What Do We Know Now?
- The Current State of the COVID-19 Pandemic in Europe: A December 2020 Update
- Implications and Prevalence of Mutations in SARS-CoV-2
- Epidemiology of COVID-19 in Healthcare Workers
- How I Managed 2 Challenging Patients With CLL During the COVID-19 Pandemic
- Reinfection with SARS-CoV-2: Published Case Reports
- Updated Data and Guidelines on COVID-19 Treatments
- Coinfections and Superinfections in Patients With COVID-19
- Management Recommendations for Preexisting Comorbidities in Patients with COVID-19
- Current Evidence on Immunomodulatory Therapies to Treat COVID-19
- COVID-19 Risk in PWH: Addressing Common Patient Concerns (CME credit)
- Updated Data and Guidance on Corticosteroids to Treat COVID-19
- Potential Long-term Sequelae of COVID-19
- Six Months Later: How COVID-19 Has Changed My Management of CLL
- How I Am Managing Patients With Advanced Breast Cancer During the COVID-19 Pandemic
- A Brief Overview: Epidemiology of Herd Immunity to SARS-CoV-2
- My Take on Key Therapy Issues for Patients With CLL During COVID-19
- Current Evidence on the Efficacy of Convalescent Plasma to Treat COVID-19
- Update on Durability of Adaptive Immune Responses to SARS-CoV-2
- Counseling Patients With CLL on Mental and Physical Health During COVID-19
- Coagulopathy in Patients With COVID-19
- SARS-CoV-2 Diagnostic Update: Epidemiological Use of Various Methods
- How I Am Managing Respiratory Symptoms in Breast Cancer Patients During the COVID-19 Pandemic
- COVID-19 in Pregnancy and Breastfeeding
- Retaining Unsuppressed Patients in HIV Care During the COVID-19 Pandemic (CME credit)
- How I Have Been Managing My Patients With CLL During the COVID-19 Pandemic in NYC: Selecting Therapy to Minimize Risk
- SARS-CoV-2 Transmission Dynamics and Prevention
- Presentation and Management of COVID-19 in Children
- How COVID-19 Is Changing the Way We Care for Patients With Breast Cancer
- COVID-19 Presentation in Immunocompromised Patients
- Data and Guidance on Dexamethasone to Treat COVID-19
- Questions on COVID-19 in Special Populations and Patients With Comorbidities
- Questions on Diagnosis, Transmission, and Epidemiology of SARS-CoV-2
- Questions on Symptoms and Clinical Manifestations of COVID-19
- Questions on COVID-19 Treatments
- COVID-19 Risk in Patients With HIV: Implications for ART Management (CME credit)
- COVID-19: Implications for Managing Antiretroviral Therapy in Patients With HIV
- Ensuring Uninterrupted ART for Patients With HIV During the COVID-19 Pandemic (CME credit)
- COVID-19: Implications for Patients With CLL
COVID-19 FAQs
Should people be tested for antibodies before getting the vaccine?
The vaccine will be licensed specifically without a need for antibody testing, and even if you were to test positive…
If you’re testing everyone at an institution with a rapid antigen test weekly, do you still need a backup test?
If you’re asymptomatic and it's part of a screening assay, you have to follow whatever the screening program is at your…
Is time of exposure a significant factor in contracting the virus?
Yes, the longer you're exposed to someone who is infected, the higher the risk of contracting the virus. That's why if you're having…
Is wearing glasses sufficient for eye protection?
We know from studies in China that wearing glasses does seem to help. However, this is not sufficient in the context of a healthcare…
COVID-19 Podcasts
- COVID-19: Answering the Questions, Part 17
- International AIDS Society COVID-19 Conference: Prevention – Rapid Recap
- COVID-19: Answering the Questions, Part 16
- COVID-19: Answering the Questions, Part 15
- COVID-19: Answering the Questions, Part 14
- COVID-19: Answering the Questions, Part 13
- COVID-19: Answering the Questions, Part 12
- Virtual ECCVID 2020 Conference – Rapid Recap
- COVID-19: Answering the Questions, Part 11
- COVID-19: Answering the Questions, Part 10
- COVID-19: Answering the Questions, Part 9
- COVID-19: Answering the Questions, Part 8
- COVID-19: Answering the Questions, Part 7
- COVID-19: Answering the Questions, Part 6
- COVID-19: Answering the Questions, Part 5
- COVID-19: Answering the Questions, Part 4
- COVID-19: Answering the Questions, Part 3
- COVID-19: Answering the Questions, Part 2
- COVID-19: Answering the Questions, Part 1
- Virtual COVID-19 2020 Conference: Rapid Audio Recap
Downloadable COVID-19 Slidesets
- Comprehensive COVID-19 Slideset: Vaccines and Variants
- Comprehensive COVID-19 Slideset: Transmission and Diagnosis
- Comprehensive COVID-19 Slideset: Special Populations and Comorbidities
- Comprehensive COVID-19 Slideset: Symptoms and Clinical Manifestations
- Comprehensive COVID-19 Slideset: Treatments
- The IAS COVID-19 Conference: Prevention — Rapid Recap
- Comprehensive COVID-19 Slideset: Emerging Data and Guidance on Diagnosis and Management
- Ensuring the Quality, Resiliency, and Continuity of Breast Cancer Care During a Pandemic: FAQs
- COVID19: Ensuring the Quality, Resiliency, and Continuity of Breast Cancer Care During a Pandemic
- Clinical Impact of New Data From the IAS 2020 Virtual COVID-19 Conference
- COVID-19 Implications for Patients with CLL